Delivery Order SPE2DB22D3301-SPE2DB25FY7GN
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,245.66 Firm Fixed Price delivery order (SPE2DX15D1120|SPE2DX25FQ1K4) is for the supply of ULTANE 250 ML PEN BOTTLE 250ML medical products. The award has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,285.60 firm fixed price delivery order is for the supply of 4565573981 - ULTANE LIQ 250ML 1S pharmaceutical products. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. government, with significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,706.01 firm fixed-price delivery order is for the supply of Ultane Liquid, a 250 mL medication. The contract has a performance period through May 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract, valued at $1,892.36, is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 17, 2025, from the Defense Logistics Agency (DLA) for ULTANE 250 ML in pen bottle format. This firm fixed-price, non-set-aside contract has a ceiling value of $2,310.24 and an ultimate completion date of September 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,686.99, is for the delivery of Ultane 250 ML Pen Bottles. The contract has a completion date of February 7, 2025, and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 250 ML pen bottles of the pharmaceutical product ULTANE. The contract has a completion date of February 1, 2024 and a potential value of $1,157.75. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, valued at $1,732.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of medical products, specifically "ULTANE 250 ML PEN BOTTLE 250ML", to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mL of Ultane in a pen bottle configuration, valued at $2,596.98. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ultane 250 ML in pen bottle format. This $1,155.12 firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 8, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7GNDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,773.37 firm fixed-price delivery order is for the supply of 250 ML bottles of the medication ULTANE. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of pharmaceuticals, medical supplies, and healthcare commodities to government customers. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through December 2026. This award is not set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/3/25 |